Issue Date: September 18, 2006
Rough Ride For Stem Cell Research
Late last month, researchers from the biotechnology company Advanced Cell Technology (ACT) published a paper in Nature indicating that they had derived embryonic stem cell lines from human embryos without destroying the embryos (C&EN, Aug. 28, page 10). The work was significant because it appeared to remove a major ethical roadblock to stem cell research, namely that an embryo must be sacrificed to develop stem cell lines that have the potential to treat . . .
To view the rest of this content, please log in with your ACS ID.
- Chemical & Engineering News
- ISSN 0009-2347
- Copyright © American Chemical Society